Webinar: How is the risk classification in AML driving treatment intensity ?
Today we had an educational webinar that gave an overview on how the risk classification in AML is driving treatment intensity. This was based on data generated in the HARMONY project.
We were joined by:
Prof. Dr.Med Lars Bulliger
Director of the Medical Department, Division of Hematology, Oncology, and Tumor Immunology
Charité – Universitätsmedizin Berlin
ALAN Steering Committee member